{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:01:28Z","timestamp":1791216088089,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0331-3","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T09:32:15Z","timestamp":1430818335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Guillaume","family":"Grolez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Sablonni\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gar\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Devedjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayah","family":"Meguig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Delmaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Defebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioav Z","family":"Cabantchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"331_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.biocel.2007.03.010","volume":"40","author":"W Breuer","year":"2008","unstructured":"Breuer W, Shvartsman M, Cabantchik ZI. Intracellular labile iron. Int J Biochem Cell Biol. 2008;40:350\u20134.","journal-title":"Int J Biochem Cell Biol"},{"key":"331_CR2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1096\/fj.04-3486fje","volume":"19","author":"H Hochstrasser","year":"2005","unstructured":"Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Kr\u00fcger R, et al. Functional relevance of ceruloplasmin mutations in Parkinson\u2019s disease. FASEB J. 2005;19:1851\u20133.","journal-title":"FASEB J"},{"key":"331_CR3","doi-asserted-by":"publisher","first-page":"18568","DOI":"10.1523\/JNEUROSCI.3768-11.2011","volume":"31","author":"S Olivieri","year":"2011","unstructured":"Olivieri S, Conti A, Iannaccone S, Cannistraci CV, Campanella A, Barbariga M, et al. Ceruloplasmin oxidation, a feature of Parkinson\u2019s disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. J Neurosci. 2011;31:18568\u201377.","journal-title":"J Neurosci"},{"key":"331_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","volume":"73","author":"S Ayton","year":"2013","unstructured":"Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, et al. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol. 2013;73:554\u20139.","journal-title":"Ann Neurol"},{"key":"331_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3940(99)00221-9","volume":"265","author":"MC Boll","year":"1999","unstructured":"Boll MC, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C. Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson\u2019s disease. Neurosci Lett. 1999;265:155\u20138.","journal-title":"Neurosci Lett"},{"issue":"10","key":"331_CR6","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1212\/01.WNL.0000144276.29988.C3","volume":"63","author":"H Hochstrasser","year":"2004","unstructured":"Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63(10):1912\u20137.","journal-title":"Neurology"},{"key":"331_CR7","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00702-012-0894-8","volume":"119","author":"A Friedman","year":"2012","unstructured":"Friedman A, Galazka-Friedman J. The history of the research of iron in Parkinsonian substantia nigra. J Neural Transm. 2012;119:1507\u201310.","journal-title":"J Neural Transm"},{"key":"331_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2013.00167","volume":"4","author":"ZI Cabantchik","year":"2013","unstructured":"Cabantchik ZI, Munnich A, Youdim MB, Devos D. Regional siderosis: a new challenge for iron chelation therapy. Front Pharmacol. 2013;4:167.","journal-title":"Front Pharmacol"},{"key":"331_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, et al. Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal. 2014;21:195\u2013210.","journal-title":"Antioxid Redox Signal"},{"key":"331_CR10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/clinchem\/20.12.1556","volume":"20","author":"KH Schosinsky","year":"1974","unstructured":"Schosinsky KH, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem. 1974;20:1556\u201363.","journal-title":"Clin Chem"},{"key":"331_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.rvsc.2006.10.011","volume":"83","author":"S Mart\u0131nez-Subiela","year":"2007","unstructured":"Mart\u0131nez-Subiela S, Tecles F, Ceron JJ. Comparison of two automated spectrophotometric methods for ceruloplasmin measurement in pigs. Res Vet Sci. 2007;83:12\u20139.","journal-title":"Res Vet Sci"},{"key":"331_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00702-014-1196-0","volume":"121","author":"M Siotto","year":"2014","unstructured":"Siotto M, Pasqualetti P, Marano M, Squitti R. Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson\u2019s disease and in hepatic encephalopathy. J Neural Transm. 2014;121:1281\u20136.","journal-title":"J Neural Transm"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0331-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0331-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T12:38:59Z","timestamp":1630586339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0331-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0331-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]},"assertion":[{"value":"19 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"74"}}